The drug, Gemcitabine is a nucleoside metabolic inhibitor that exhibits antitumor activity. Gemcitabine kills cells undergoing DNA synthesis and blocks the progression of cells through the G1/S-phase boundary. Healthcare providers use this drug in treating patients who have advanced ovarian cancer, metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and pancreatic cancer. Gemcitabine single-dose vials come in 1 g and 200 mg to administer intravenously. The active ingredient in the vials is Gemcitabine with inactive ingredients are mannitol and sodium acetate. One should store the drug Gemcitabine at controlled room temperature 20° to 25°C (68° to 77°F).
Gemcitabine 1 g is readily present with several licensed pharmaceutical suppliers. If you want to know more about Gemcitabine, reach us via 18008891064.
0
